Stem Cell Market Research Reports & Industry Analysis
Cells must meet very specific criteria in order to be termed stem cells. They must: produce copies themselves; proliferate at a rapid rate; and display certain proteins on their surface that indicate a capacity to differentiate into other tissues, such as bone and cartilage. A stem cell line is a group of cells that all descend from a single original stem cell. Symmetric division gives rise to two identical daughter cells both endowed with stem cell properties. Asymmetric division produces only one stem cell and a progenitor cell with limited self-renewal potential.
Stem Cell Industry Research & Market Reports
-
Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
... thrive. Whether you are a biotech executive, investor, R&D leader, or regulatory strategist, this report provides data-driven insights to inform your next move. TWO REPORTS FOR THE PRICE OF ONE Cell and Gene Therapy Market ... Read More
-
2025 Human Reproductive and Stem Cell Bank Services Global Market Size & Growth Report with Updated Analysis & Forecasts
... Middle East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling human reproductive and ... Read More
-
Single Cell Analysis Market Size, Share & Trends By Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2029
... growth of this market can be attributed to the increasing focus on personalized medicine. The rising R&D investments pharmaceutical & biotechnology industries is propelling the growth of single-cell analysis. Additionally, factors such as growth in ... Read More
-
Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033
... growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market. ... Read More
-
Cord Blood Stem Cells – A Global Market Overview
... (HSCs) that have substantial therapeutic potential. These stem cells treat various conditions, including cancers such as leukemia and lymphoma, genetic disorders, immune deficiencies, and certain types of anemia. The collection process uses a ""closed technique"" ... Read More
-
GMP Cell Banking Services
... 2030, growing at a CAGR of 15.2% over the analysis period 2024-2030. Mammalian Cells, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$1.5 Billion by the ... Read More
-
Allogeneic Stem Cells
... at a CAGR of 10.9% over the analysis period 2024-2030. Regenerative Therapy Application, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$1.6 Billion by the end ... Read More
-
Canine Stem Cell Therapy
... 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Allogeneic Stem Cells, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$174.8 Million by ... Read More
-
CAR T-cell Therapy
... at a CAGR of 22.0% over the analysis period 2024-2030. DLBCL Indication, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.1 Billion by the end of ... Read More
-
Cord Blood Banking Services
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Private Blood Banks, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$79.3 Billion by ... Read More
-
Primary Immunodeficiency Therapeutics
... at a CAGR of 6.4% over the analysis period 2024-2030. Antibody Deficiency Disease, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$8.5 Billion by the end ... Read More
-
Amniotic Products
... CAGR of 8.1% over the analysis period 2024-2030. Amniotic Membranes, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$1.2 Billion by the end of the analysis ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
Rat Model
... CAGR of 7.1% over the analysis period 2024-2030. Inbred Rat Model, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$901.6 Million by the end of the ... Read More
-
Stem Cell Services
... at a CAGR of 9.8% over the analysis period 2024-2030. The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 9.0% CAGR The Stem Cell Services market in the U.S. ... Read More
-
Live Cell Imaging
... at a CAGR of 7.5% over the analysis period 2024-2030. Live Cell Imaging Instruments, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.9 Billion by the ... Read More
-
Cell Therapy
... CAGR of 14.1% over the analysis period 2024-2030. Allogenic Cell Therapy, one of the segments analyzed in the report, is expected to record a 12.8% CAGR and reach US$23.4 Billion by the end of the ... Read More
-
Amyloidosis Treatment
... CAGR of 6.8% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$3.7 Billion by the end of the analysis period. ... Read More
-
Stem Cell Manufacturing
... at a CAGR of 7.8% over the analysis period 2024-2030. Culture Media, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$9.2 Billion by the end of ... Read More
-
Stem Cell Therapy
... at a CAGR of 16.4% over the analysis period 2024-2030. Allogeneic Stem Cell Therapy, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$1.0 Billion by the ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Primary Cells
... CAGR of 7.1% over the analysis period 2024-2030. Human Primary Cells, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$1.4 Billion by the end of the ... Read More
-
Cell Expansion
... CAGR of 14.8% over the analysis period 2024-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the ... Read More
-
Humanized Mouse and Rat Model
... Million by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Humanized Rat Models, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$13.6 ... Read More
-
Stem Cell Assays
... at a CAGR of 17.9% over the analysis period 2024-2030. Instruments Component, one of the segments analyzed in the report, is expected to record a 18.4% CAGR and reach US$6.1 Billion by the end of ... Read More
Research Assistance
